EP3685815B1 - Dispositif de distribution des médicaments et procédé de fonctionnement associé - Google Patents

Dispositif de distribution des médicaments et procédé de fonctionnement associé Download PDF

Info

Publication number
EP3685815B1
EP3685815B1 EP19219741.6A EP19219741A EP3685815B1 EP 3685815 B1 EP3685815 B1 EP 3685815B1 EP 19219741 A EP19219741 A EP 19219741A EP 3685815 B1 EP3685815 B1 EP 3685815B1
Authority
EP
European Patent Office
Prior art keywords
control means
medicaments
dispensing
primary
electrical power
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP19219741.6A
Other languages
German (de)
English (en)
Other versions
EP3685815C0 (fr
EP3685815A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JDM Innovation GmbH
Original Assignee
JDM Innovation GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JDM Innovation GmbH filed Critical JDM Innovation GmbH
Publication of EP3685815A1 publication Critical patent/EP3685815A1/fr
Application granted granted Critical
Publication of EP3685815C0 publication Critical patent/EP3685815C0/fr
Publication of EP3685815B1 publication Critical patent/EP3685815B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • A61J7/0084—Medicament distribution means for multiple medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0418—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
    • A61J7/0436—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system resulting from removing a drug from, or opening, a container
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
    • A61J7/0481—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers working on a schedule basis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/30—Compliance analysis for taking medication

Definitions

  • the disclosure relates to a medication dispensing device.
  • U.S. 2011/121019 A1 describes a medication dispensing device.
  • U.S. 5,945,651A describes a remotely programmable medication dispensing device.
  • Preferred embodiments relate to a medication delivery device according to claim 1, wherein the device comprises a primary controller for controlling at least a first component of the device and a secondary controller for controlling at least a second component of the device.
  • the first component is, for example, a component of the device that is (absolutely) necessary for dispensing the medicaments, e.g. a transport device for conveying the medicaments.
  • the second component is, for example, a component of the device that is not or not absolutely necessary for dispensing the medication, e.g. a communication interface that enables data exchange between the device and at least one other unit (not shown) allows.
  • This advantageously enables flexible operation of the device, and in particular an essential function of the device, namely the dispensing of medication, can be carried out or maintained if necessary solely under the control of the primary control device, e.g. when the secondary control device fails or is inoperative .
  • the device is designed to dispense medicines arranged in blister bags.
  • a blister tube is a product that is essentially in the form of a strip, in which a number of individual packaging units, which are also referred to as blister bags or tubular blisters, are arranged one behind the other.
  • a blister tube can be designed, for example, as a medication blister tube, which has one or more medications, such as tablets, in each of the individual blister bags.
  • the device can advantageously output one or more blister tubes.
  • the device has a storage container for medication to be dispensed, in particular blister bags, and a transport device for conveying the medication, in particular blister bags, out of the storage container.
  • the primary control device is designed to control the transport device.
  • the primary control device has at least one computing device, at least one memory device assigned to the computing device for at least temporarily storing a first computer program, the first computer program being designed in particular to control an operation of the primary control device.
  • the primary control device is designed to store first control information at least temporarily, the first control information having in particular information on taking medications and/or medications characterizing administration times or medication information characterizing the medications.
  • the primary control device has a first data interface for the preferably bidirectional exchange of data with at least the secondary control device, wherein the first data interface in particular also has a serial data interface, preferably of the Universal Serial Bus, USB, type .
  • the primary control device has at least one control interface acting on the secondary control device.
  • the primary control device is designed to reset (i.e. reset) the secondary control device a) via the at least one control interface, in particular to put it into a reset state, and/or b) via to move the at least one control interface from a first operating state to a second operating state, wherein in particular the first operating state is an energy-saving state and the second operating state is an active operating state.
  • the secondary control device can preferably send the data periodically to the primary control device in order to signal to it that it is (still) functional.
  • the primary control device is designed to switch the secondary control device, in particular repeatedly, more particularly periodically, from an energy-saving state to an active operating state.
  • the device has at least one first reading device for reading in a machine-readable code, in particular the machine-readable code containing information from characterized by the medication processed or processable by means of the device, wherein in particular the first reading device has a barcode reader or is designed as a barcode reader.
  • the primary control device is preferably designed to control an operation of the first reading device.
  • barcodes arranged on blister bags can be detected by means of the first reading device and evaluated, for example, by the primary control device.
  • the barcode which generally characterizes the contents of the blister bag, can be compared with control information, on the basis of which the device or the primary control device controls the dispensing of the blister bag. If, for example, there is a discrepancy between the mentioned control information and the data of the barcode, the blister bag can be dispensed with and/or another error reaction can be initiated.
  • the primary control device is designed to control the transport device autonomously, in particular without the involvement of the secondary control device.
  • the primary control device is designed to control the transport device as a function of the first control information.
  • the device has an openable housing and/or an openable housing part and a locking device for locking and/or unlocking the openable housing and/or the openable housing part, with the primary control device being designed to activate the locking device , in particular for locking and/or unlocking the openable housing and/or the openable housing part.
  • the secondary control device has at least one computing device, at least one memory device assigned to the computing device for at least temporarily storing a second computer program, the second computer program being designed in particular to control an operation of the secondary control device.
  • the secondary control device has a first data interface for the preferably bidirectional exchange of data with at least the primary control device, wherein the first data interface in particular also has a serial data interface, preferably of the Universal Serial Bus, USB, type .
  • the secondary control device has at least one control interface acting on the primary control device.
  • the secondary control device is designed to reset the primary control device via the at least one control interface.
  • the secondary control device is designed to periodically receive data from the primary control device and to initiate a second error response if no data is received from the primary control device for a specifiable second waiting time, with the second error response in particular or resetting the primary controller.
  • the primary control device can preferably send the data periodically to the secondary control device in order to signal to it that it is (still) functional.
  • the device has at least one of the following elements: a display device, a device for outputting and/or inputting acoustic signals, in particular speech, a digital image acquisition device.
  • the secondary control device has at least one of the following elements: an interface for controlling a display device, an interface for controlling a device for outputting and/or inputting acoustic signals, an interface for Control of a or the digital image acquisition device, at least one data interface for establishing a data connection with at least one external unit, in particular a server and/or a cloud server system.
  • the secondary control device is designed to a) monitor operation of at least one component of the device and/or b) send information characterizing an operating state of at least one component of the device to an external unit.
  • the secondary control device is designed to store second control information at least temporarily, the second control information having in particular information on taking medication and/or medication that characterizes administration times or medication information that characterizes the medication.
  • the device is designed to receive third control information from an external unit and to control operation of at least one component of the device depending on the third control information, with the device being designed in particular to dispense medication execute depending on the third control information.
  • the device has a primary electrical energy supply unit and a secondary electrical energy supply unit, with the primary electrical energy supply unit in particular being designed for connection to a power grid, in particular an AC grid, with the secondary electrical energy supply unit in particular having at least one of the following elements includes: battery, accumulator, ultracapacitor. More preferably, chargeable electrical energy stores of the secondary electrical energy supply unit can be charged by the primary electrical energy supply unit.
  • the secondary electrical energy supply unit is designed to at least temporarily supply at least some components of the device with electrical energy, wherein in particular the secondary electrical energy supply unit is designed to at least temporarily supply at least the primary control device and the transport device with electrical to supply energy.
  • the device is designed to detect a fault and/or failure of the power grid and to switch from a first operating mode, in which the device can be supplied by the power grid using the primary electrical energy supply unit, to a second operating mode change, wherein in the second operating mode at least some components of the device can be supplied with electrical energy by means of the secondary electrical energy supply unit.
  • the device is designed to signal the disruption and/or failure of the power grid to at least one external unit.
  • the device is designed to determine future dispensing times at which medication is to be dispensed by the device as a function of the first control information and/or the second control information.
  • the device is designed to determine a minimum remaining operating time of the device in the second operating mode, the future output times being taken into account in particular for this purpose.
  • the device is designed to determine a first number that characterizes how many of the future output times for which operation of the device in the second operating mode can be maintained.
  • the device is designed to output the minimum remaining operating time and/or the first number to a user of the device and/or to signal at least one external unit.
  • the device is designed to determine whether the minimum remaining operating time allows medication to be dispensed for a predeterminable second number of dispensing times of the future dispensing times.
  • the device is designed to, if the minimum remaining operating time no longer allows medication to be dispensed for a specifiable second number of dispensing times of the future dispensing times, medicaments corresponding to a specifiable third number of future dispensing times an unscheduled dispensing of medication before these future dispensing times, in particular within the minimum remaining operating time, more particularly immediately after it has been determined that the minimum remaining operating time no longer allows medication to be dispensed for the predefinable second number of dispensing times.
  • the device is designed to obtain approval for the unscheduled dispensing of medication from an external unit and/or a user of the external unit before the unscheduled dispensing of medication.
  • the device is designed to put at least one component of the device into an energy-saving state or to deactivate it in the second operating mode.
  • an electrical capacity of the secondary electrical energy supply unit is so large that the minimum remaining operating time is at least approximately 12 hours, preferably at least approximately 24 hours.
  • a or the electrical capacity of the secondary electrical energy supply unit is at least approximately 2000 milliampere hours.
  • FIG. 15 Further preferred embodiments relate to a method for operating a device for dispensing medication according to claim 15, in particular a device according to the embodiments, wherein the device has a primary control device for controlling at least a first component of the device and a secondary control device for controlling at least a second Having component of the device, wherein the primary controller controls the at least one first component, and wherein the secondary controller controls the at least one second component.
  • the device has a reservoir for medication to be dispensed, in particular blister bags, and a transport device for conveying the medication, in particular blister bags, out of the reservoir, with the device dispensing medication arranged in blister bags in particular.
  • the primary control device controls the transport device.
  • the primary control device at least temporarily stores first control information, with the first control information having in particular information on taking medication and/or medication characterizing administration times or medication information characterizing the medication, with the secondary control device in particular storing second control information at least temporarily, wherein the second control information includes, in particular, information on taking medication that characterizes administration times and/or medication or medication information that characterizes the medication.
  • the primary control device has a first data interface for the preferably bidirectional exchange of data with at least one further unit, in particular with the secondary control device.
  • the first data interface has a serial data interface, preferably of the Universal Serial Bus, USB, type, the primary control device having at least one control interface acting on the secondary control device, the primary control device controlling the secondary control device a) via resets the at least one control interface, in particular to a reset state, and/or b) sets it from a first operating state to a second operating state via the at least one control interface, with the first operating state in particular being an energy-saving state and the second operating state being on active operating state.
  • a serial data interface preferably of the Universal Serial Bus, USB, type
  • the primary control device having at least one control interface acting on the secondary control device, the primary control device controlling the secondary control device a) via resets the at least one control interface, in particular to a reset state, and/or b) sets it from a first operating state to a second operating state via the at least one control interface, with the first operating state in particular being an energy-saving state and the second operating state being on active operating state.
  • the primary control device periodically receives data from the secondary control device and initiates a first error response if no data is received from the secondary control device for a specifiable first waiting time, with the first error response in particular including a resetting of the secondary control device .
  • the primary control device controls the transport device autonomously at least at times, in particular without the involvement of the secondary control device.
  • the secondary control device has a first data interface for the preferably bidirectional exchange of data with at least the primary control device, wherein the first data interface in particular also has a serial data interface, preferably of the Universal Serial Bus, USB, type , wherein the secondary control device has at least one control interface acting on the primary control device, wherein the secondary control device resets the primary control device via the at least one control interface, in particular into a reset state.
  • the secondary control device periodically receives data from the primary control device and initiates a second error response if no data is received from the primary control device for a second, specifiable waiting time, with the second error response in particular including a resetting of the includes primary controller.
  • the secondary control device a) monitors operation of at least one component of the device and/or b) sends information characterizing an operating state of at least one component of the device to a or the external unit.
  • the device receives third control information from an external unit and controls operation of at least one component of the device depending on the third control information, with the device dispensing medication in particular depending on the third control information.
  • the device has a primary electrical energy supply unit and a secondary electrical energy supply unit, with the primary electrical energy supply unit in particular being designed for connection to a power grid, in particular an AC grid, with the secondary electrical energy supply unit in particular having at least one of the following elements comprises: battery, accumulator, ultracapacitor, wherein the secondary electrical energy supply unit at least temporarily supplies at least some components of the device with electrical energy, wherein in particular the secondary electrical energy supply unit at least temporarily supplies at least the primary control device and the transport device with electrical energy.
  • the device detects a fault and/or failure of the power grid and switches from a first operating mode, in which the device can be supplied by the power grid using the primary electrical energy supply unit, to a second operating mode, in which second operating mode, at least some components of the device are supplied with electrical energy by means of the secondary electrical energy supply unit, with the device in particular signaling the disruption and/or failure of the power grid to at least one external unit.
  • the device determines future dispensing times at which medication is to be dispensed by the device as a function of the first control information and/or the second control information.
  • the device determines a minimum remaining operating time of the device in the second operating mode, the future output times being taken into account in particular for this purpose.
  • the device determines a first number that characterizes how many of the future output times for which operation of the device in the second operating mode can be maintained, in particular the device determining the minimum remaining operating time and/or the first number outputs to a user of the device and/or signals to at least one external unit.
  • the device determines whether the minimum remaining operating time allows medication to be dispensed for a predeterminable second number of dispensing times of the future dispensing times, with the device in particular when the minimum remaining operating time no longer permits dispensing of medication for a predeterminable second number of dispensing times of the future dispensing times, dispenses medication corresponding to a predeterminable third number of future dispensing times as part of an unscheduled dispensing of medication before these future dispensing times, in particular within the minimum remaining operating time, more particularly immediately after it has been determined is that the minimum remaining operating time no longer allows medication to be dispensed for the predefinable second number of dispensing times.
  • the device obtains a release for the unscheduled dispensing of medication from an external unit and/or a user of the external unit before the unscheduled dispensing of medication.
  • FIG. 1 schematically shows a simplified block diagram of an apparatus 100 for dispensing medication.
  • the device 100 has a primary control device 110 for controlling at least one first component K1 of the device 100, cf. the double arrow A1.
  • the device 100 also has a secondary control device 120 for controlling at least one second component K2 of the device 100, cf. the double arrow A2.
  • the first component K1 is, for example, a component of the device 100 that is necessary for dispensing the medication, for example a transport device 132 ( 4 ) to convey the medicines.
  • the second component K2 ( 1 ) For example, such a component of the device 100 that is not or not absolutely necessary for dispensing the medication, e.g. a communication interface that enables data exchange between the device 100 and at least one other unit (not in 1 shown) allows.
  • This advantageously enables flexible operation of the device 100, and in particular an essential function of the device 100, namely dispensing medication, can be carried out or maintained if necessary solely under the control of the primary control device 110, for example when the secondary control device 120 fails or has no function.
  • the device 100 has a primary electrical power supply unit 180, the primary electrical power supply unit 180 being designed in particular for connection to a power grid (not shown), in particular an AC power grid (e.g. with a nominal voltage of approximately 230 volts). .
  • a secondary electrical energy supply unit 181 is optionally provided, which has at least one of the following elements: battery, accumulator, ultracapacitor (or supercapacitor, eg double-layer capacitor).
  • the optional secondary electrical energy supply unit 181 is designed to supply at least some components K1, K2, 110, 120 of the device 100 with electrical energy, at least temporarily, with the secondary electrical energy supply unit 181 in particular being designed for this at least temporarily at least the primary control device 110 and said transport device 132 ( 4 ) to supply with electrical energy.
  • the device 100 is designed to be placed in blister bags 200, cf. 2 to dispense ordered medication.
  • a blister tube 200 is a substantially band-shaped one Product in which a plurality of individual packaging units, which are also referred to as blister bags 210, 211, 212 or tubular blisters, are arranged one behind the other.
  • a blister tube 200 can be designed, for example, as a drug blister tube, which has one or more drugs, such as tablets, in each of the individual blister bags 210, 211, 212.
  • the device 100 ( 1 ) output one or more blister tubes according to further preferred embodiments.
  • FIG 2 1 schematically shows a side view of a blister tube 200 according to preferred embodiments.
  • the blister tube 200 is designed as a medication blister tube and has, for example, three blister bags 210 , 211 , 212 which are connected to one another by connecting elements 202 .
  • the connecting elements 202 can, for example, be welded sections of the same material (eg a plastic film) from which the blister bags 210, 211, 212 are also made.
  • a longitudinal direction of the blister tube 200 extends according to FIG figure 2 along a coordinate axis y, the length of an individual blister bag 211 being indicated by the reference L.
  • a height of the blister tube 200 extends in figure 2 in the vertical direction, compare the coordinate axis z, and a width of the blister tube 200 extends in figure 2 in a direction perpendicular to the plane of the drawing, see the coordinate axis x.
  • the first blister bag 210 has two different tablets 210a, 210b, the second blister bag 211 has a total of three essentially identical tablets 211a, and the third blister bag 212 has three different tablets 212a, 212b, 212c.
  • figure 3 shows a schematic side view of a partially wound up blister tube 200a, of which the blister bags that have already been at least partially unwound are denoted by reference numerals 213, 214, 215 and a portion that is still wound up is denoted by reference numeral 216.
  • the blister tube 200a according to figure 3 Blister bags containing similar and/or different medications, in particular tablets.
  • the configuration of the blister tube 200a shown can be provided, for example, in a transport container (not shown) and distributed in this form to customers, for example patients, for whom the medication in the blister bags is intended, for example in order to be incorporated into the device 100 ( 1 ) to be inserted according to the embodiments, which causes an output of individual (or several) blister bags, for example depending on a medication plan or correspondingly stored control information, in particular at predeterminable output times.
  • FIG. 1 schematically shows a side view of a device 100a for dispensing medicines or medicinal products arranged in blister bags 200b according to further preferred embodiments.
  • the device 100a has a housing 102 that defines an interior space 102a that is essentially protected from external influences.
  • a reservoir 130 for medication to be dispensed, in particular blister bags 200b, is arranged in the interior space 102a and can be filled with new blister tubes 200a ( 3 ) can be refilled.
  • the device 100a also has a transport device 132 for conveying the medicaments, in particular the blister bags 200b, out of the storage container 130 and more preferably through a dispensing opening 134 in the housing 102, see arrow A3.
  • the transport device 132 can have, for example, one or more transport rollers and/or conveyor belts (not shown) or the like, which are driven, for example, by an electric motor.
  • the primary control device 110 is designed to control the transport device 132, for example one or more electric motors (not shown) of the transport device 132.
  • FIG. 11 schematically shows a simplified block diagram of a primary controller 1100 according to further preferred embodiments.
  • the primary controller 110 from 1 , 4 the configuration 1100 according to figure 5 exhibit.
  • Primary control device 1100 has at least one computing device 1102, at least one storage device 1104 assigned to computing device 1102 for at least temporarily storing a first computer program PRG1, wherein the first computer program PRG1 is designed in particular to control an operation of primary control device 1100.
  • the computing device 1102 has at least one of the following elements: a microprocessor, a microcontroller, a digital signal processor (DSP), a programmable logic device (e.g. FPGA, field programmable gate array), an ASIC (application-specific integrated circuit). Combinations of these are also conceivable in further preferred embodiments.
  • DSP digital signal processor
  • FPGA field programmable gate array
  • ASIC application-specific integrated circuit
  • the computing device 1102 of the primary control device 1100 has a microcontroller, in particular a 32-bit microcontroller, preferably based on the ARM Cortex-M4 architecture.
  • the memory device 1104 has at least one of the following elements: a volatile memory 1104a, in particular main memory (RAM), a non-volatile memory 1104b, in particular flash EEPROM.
  • the first computer program PRG1 is preferably stored in the non-volatile memory 1104b.
  • the primary control device 1100 is designed to store first control information SI1 at least temporarily (present, for example, in the non-volatile memory 1104b), the first control information SI1 being in particular administration information El characterizing administration times of medication 210a, 210b, . ., 212c ( 2 ) and/or medication or the medication 210a, 210b, .., 212c have medication information MI characterizing them.
  • the administration times correspond, for example, to those times at which a user has to take specific medication.
  • Dispensing times for example, at which the device dispenses the specific medication, correspond to the administration times.
  • the primary control device 1100 is designed to dispense medication at one or more dispensing times, the dispensing times being e.g. ascertainable as a function of the intake information El, e.g. under control of the first computer program PRG1.
  • the primary control device 1100 has a first data interface 1106 for the preferably bidirectional exchange A4 of data with at least the secondary control device 120 ( 1 ), wherein the first data interface 1106 in particular also has a serial data interface, preferably of the Universal Serial Bus, USB, type, for example compatible with the USB 1.1 standard and/or with the USB 2.0 standard and/or with the USB 3.0 standard and /or to the USB 3.1 standard.
  • a serial data interface preferably of the Universal Serial Bus, USB, type, for example compatible with the USB 1.1 standard and/or with the USB 2.0 standard and/or with the USB 3.0 standard and /or to the USB 3.1 standard.
  • the primary control device 1100 has at least one on the secondary control device 120 ( 1 ) acting control interface 1108 ( figure 5 ) having.
  • Control information A5 or control commands can be transmitted to the secondary control device 120 via the control interface 1108, which, for example, allow the operation of the secondary control device 120 to be influenced by the primary control device 110 make possible.
  • the control interface 1108 has a serial data connection and/or a parallel data connection or individual data lines to the secondary control device 120 .
  • the primary control device 1100 has at least one transport device interface 1109, via which the primary control device 1100 sends a transport device 132 (see Fig. 7 ) of device 100 for dispensing medication, in particular blister bags, can control, for example, one or more electric motors of transport device 132.
  • figure 6 12 schematically shows a simplified block diagram of a secondary controller 1200 according to further preferred embodiments.
  • the secondary controller 120 may be off 1 , 4 the configuration 1200 according to 6 exhibit.
  • Secondary control device 1200 has at least one computing device 1202, at least one storage device 1204 assigned to computing device 1202 for at least temporarily storing a second computer program PRG2, the second computer program PRG2 being designed in particular to control the operation of secondary control device 1200.
  • the computing device 1202 has at least one of the following elements: a microprocessor, a microcontroller, a digital signal processor (DSP), a programmable logic device (e.g. FPGA, field programmable gate array), an ASIC (application-specific integrated circuit). Combinations thereof are also conceivable in further preferred embodiments.
  • the computing device 1202 of the secondary control device 1200 has a microprocessor, in particular a microprocessor with a computing core (“single core”) or multiple computing cores (“multi-core”), more particularly a 64-bit microprocessor with four computing cores .
  • the memory device 1204 has at least one of the following elements: a volatile memory 1204a, in particular main memory (RAM), a non-volatile memory 1204b, in particular flash EEPROM.
  • the second computer program PRG2 is preferably stored in the non-volatile memory 1204b.
  • the secondary control device 1200 has a first data interface 1206 for the preferably bidirectional exchange A6 of data with at least the primary control device, with the first data interface in particular also being a serial data interface, preferably from the Universal Serial Bus, USB , type has.
  • the first data interface 1206 of the secondary controller 1200 is of the same type as the first data interface 1106 of the primary controller 1100 or is compatible therewith.
  • the secondary control device 1200 has at least one control interface 1208 ( 6 ) having.
  • Control information A7 or control commands can be transmitted to the primary control device 110, 1100 via the control interface 1208, which, for example, enable the operation of the primary control device 110, 1200 to be influenced by the secondary control device 120, 1200.
  • the secondary control device 1200 is designed to at least temporarily store second control information SI2 (present, for example, in the non-volatile memory 1204b), the second control information SI2 characterizing in particular administration times Intake information EI' of medication and/or medication or medication information MI' characterizing the medication.
  • second control information SI2 present, for example, in the non-volatile memory 1204b
  • the second control information SI2 characterizing in particular administration times Intake information EI' of medication and/or medication or medication information MI' characterizing the medication.
  • the secondary control device 1200 transmits the intake information EI' and/or the drug information MI' or generally the second control information SI2 or at least parts thereof to the primary control device 1100, e.g. via the first data interface 1106, 1206, which, in further preferred embodiments, is embodied, for example, as a USB data connection.
  • the primary control device 1100 can be supplied, preferably repeatedly, in particular periodically, with the second control information SI2, which can be stored at least temporarily by the primary control device 1100 in the form of the first control information SI1.
  • the primary control device 1100 can first process the second control information SI2 transmitted from the secondary control device 1200 to the primary control device 1100 (e.g. via the USB interface 1106, 1206), and at least parts of the second control information SI2 received during this processing store processed second control information SI2 as first control information Si1 locally (in the primary control device 1100, for example in the flash memory 1104b).
  • the first control information SI1 is at least partially organized or stored in the form of a table and/or list or the like, for example in the form of a list of future administration times and/or dispensing times of the drugs 200b that can be dispensed ( 4 ), to which the device 100 - at least under the control of the primary control device 1100 - is to dispense the corresponding medication 200b.
  • a list can contain, for example, approximately 10 to approximately 1000 elements or lines, in particular between approximately 20 to approximately 100 elements or lines, i.e. times of administration or times of dispensing and possibly information associated with the respective times of administration (e.g. medication information MI). exhibit.
  • the device 100, 100a ( 1 , 4 ) is designed to be controlled by an external entity (not in 1 , 4 shown) to receive third control information and to control an operation of at least one component 110, 1100, 120, 1200 of the device 100, 100a depending on the third control information, wherein in particular the device 100, 100a is designed to dispense medication 200b ( 4 ) to execute depending on the third control information.
  • the device 100, 100a from the third control information for example, the second control information SI2 ( 6 ) and/or the first control information SI1 ( figure 5 ) derive.
  • the device 100a ( 4 ) has at least one first reading device 140 for reading in a machine-readable code, with the machine-readable code in particular characterizing information on medication 200b processed or capable of being processed by means of device 100a, with first reading device 140 in particular having a barcode reader or being embodied as a barcode reader.
  • the primary control device 110, 1100 is preferably designed to control an operation of the first reading device 140.
  • Attached information (e.g. one-dimensional or two-dimensional barcode) can be recorded, and the information recorded can be compared with the first and/or second control information SI1, SI2 or information derived therefrom. In this way it can be ensured, for example, that only correct medication or blister bags are dispensed, with incorrect medication being able to be discarded, for example.
  • the primary control device 1100 ( figure 5 ) is designed to move the transport device 132 ( 4 ) depending on the first control information SI1 to drive.
  • the device 100a has an openable housing 102 and/or an openable housing part and a locking device 104 for locking and/or unlocking the openable housing 102 and/or the openable housing part, with the primary control device 110 being configured for this purpose is to actuate the locking device 104, in particular for locking and/or unlocking the openable housing 102 and/or the openable housing part.
  • the locking device 104 can also be controlled, for example, by an external unit which can send appropriate commands to the device for this purpose, for example via a data interface 1216 ( 6 ).
  • the device 100a is designed to unlock the openable housing 102 and/or the openable housing part, in particular to unlock it automatically (without interaction with a user B) if at least one of the following conditions is present: a ) an electrical power supply of the device 100a and/or at least one component 110 of the device 100a can no longer be maintained for a predeterminable required first operating time (or one or the minimum remaining operating time is less than the predeterminable required first operating time), b) a malfunction of the device 100a and/or at least one component of the device 100a.
  • the device 100a is designed to check, in particular to check periodically, the presence of at least one of the aforementioned conditions a), b).
  • the primary control device 110, 1100 has a maximum electrical power consumption of 40 watts, in particular 32 watts.
  • the device 100b has at least one of the following elements: a display device 150 (e.g. flat screen, in particular touch-sensitive flat screen), a device 160 for outputting and/or inputting acoustic signals, in particular speech, a digital image acquisition device 170 (e.g. digital camera or webcam).
  • a display device 150 e.g. flat screen, in particular touch-sensitive flat screen
  • a digital image acquisition device 170 e.g. digital camera or webcam
  • the secondary control device 1200 ( 6 ) has at least one of the following elements: an interface 1210 for controlling a display device 150 ( 7 ), an interface 1212 ( 6 ) for controlling a device 160 for outputting and/or inputting acoustic signals, an interface 1214 for controlling a digital image acquisition device 170, at least one data interface 1216 for establishing a data connection with at least one external unit, in particular a server 252 and/or a cloud server system 250.
  • the secondary control device 1200 is preferably designed to provide a graphical user interface via the display device 150, for example under the control of the second computer program PRG2.
  • the device 100b has an optional input element 152, for example an input button or button, in particular a push button.
  • the device 100b has an illumination device 152a for illuminating the input element 152 and/or other components or areas of the device 100b.
  • the lighting device 152a has one or more semiconductor light sources, in particular LEDs (preferably RGB LEDs), which are designed and arranged in particular in such a way that they cover at least part of the optional pushbutton 152 (and/or one surrounding the pushbutton 152 Area of the housing 102, in particular a housing wall in which the push button 152 is preferably installed) can illuminate at least temporarily.
  • LEDs preferably RGB LEDs
  • the lighting device 152a or at least one light source of the lighting device 152a surrounds the optional pushbutton 152, e.g. in the form of a ring or rounded rectangle, at least partially, preferably completely.
  • the LEDs of the lighting device 152a can alternatively or additionally also illuminate a symbol on an actuation surface of the optional push button 152 .
  • the device 100b can also be designed to use or to control the lighting device 152a to illuminate the optional push button 152 for the visual signaling of information to a user B.
  • the device 100b is designed to signal at least one operating state of the device 100b and/or at least one component of the device 100b by means of the lighting device 152a, for example using light of different colors (e.g. red, green, etc., possibly also by flashing).
  • the primary control device 110, 1100 is designed to determine and/or monitor the state of the pushbutton 152. Inputs made by a user B of the device 100b using the pushbutton 152 can thus preferably be recognized directly by the primary control device 110, 1100 and, if necessary, processed.
  • the primary control device 110, 1100 is designed to assume an energy-saving state at least temporarily. In further preferred embodiments, the primary control device 110, 1100 is designed to be switched from its energy-saving state to a different operating state when the push button 152 is actuated. For example, a signal from the push button 152 and/or a signal derived therefrom can be used in further preferred embodiments to apply to an interrupt request (interrupt) input of the primary control device 110, 1100, which enables an efficient change of operating state.
  • interrupt interrupt
  • the primary control device 110, 1100 is designed to control the lighting device 152a.
  • the primary control device 110, 1100 is designed to signal at least one operating state of the device 100b and/or at least one component of the device 100b by means of the lighting device 152a, for example using light of different colors (e.g. red , green, etc., possibly also by flashing).
  • the device 100b is designed to signal a forthcoming and/or currently available dispensing time for the dispensing of medication, in particular in the form of a blister bag. In this way, the user B can be made aware that it may be necessary to remove the blister bag from the device 100b and/or to take the corresponding medication.
  • the signaling can take place, for example, by outputting corresponding information via the graphical user interface on the display device 150, in particular under the control of the secondary control device 120, 1200.
  • the signaling can take place, for example, by outputting corresponding information using lighting device 152a (e.g. flashing with a specifiable light color), in particular under the control of primary control device 110, 1100.
  • lighting device 152a e.g. flashing with a specifiable light color
  • the signaling can also take place by outputting corresponding information via the graphical user interface on display device 150, in particular under the control of secondary control device 120, 1200, and by outputting corresponding information by means of lighting device 152a (e.g. flashing with a specifiable light color), in particular under the control of the primary controller 110, 1100.
  • lighting device 152a e.g. flashing with a specifiable light color
  • the signaling described above can optionally be supplemented by an acoustic signal.
  • the device 100b is designed to inform a user B by means of a signal, for example by means of the display device 150 and/or the lighting device 152a (and/or acoustically), that a blister bag is about to be issued to wait for an input from user B (whereby the input from user B is, for example, a confirmation of the previous signaling and/or a request for the blister bag to be dispensed), and (in particular only) after the input from user B the blister bag also to the user to spend B.
  • the blister bag can be held within the housing 102 of the device for possible dispensing prior to dispensing, but in this situation the blister bag thus held is not already removable from the outside.
  • waiting for user B's input can include, for example, at least one of the following elements: waiting for user B's input on the (touch-sensitive) display device 150, waiting for user B's input using the optional push button 152.
  • the secondary control device 1200 also has at least one transport device interface (not in 6 shown, comparable to item 1109 figure 5 ), via which the secondary control device 1200 can control the transport device 132 of the device 100, 100a, 100b for dispensing medication, in particular blister bags.
  • FIG 8 12 shows a simplified block diagram in accordance with further preferred embodiments.
  • Control devices 110, 120 are shown, with data interface 1216 of secondary control device 120 or 1200 having a first, in particular IP (Internet Protocol)-based interface 1216a, which, for example, has a data connection A11 via LAN and/or WLAN to at least one private and/or public network 254 (e.g. internet or cloud).
  • the data interface 1216 of the secondary control device 120 or 1200 also has an optional second interface 1216b, which establishes, for example, a wireless data connection A12 using a mobile (cellular) communication system 256, the communication system 256 being a 3G system or a 4G system, for example (e.g. LTE) or a 5G system.
  • a mobile (cellular) communication system 256 being a 3G system or a 4G system, for example (e.g. LTE) or a 5G system.
  • Data interface 1216 enables efficient data exchange between device 100 or its secondary control device 120, 1200 with at least one unit located remotely from device 100 or a system located remotely from device 100, in particular an information technology (IT) system, e.g. cloud system 250 and/or the server 252 and/or a computer or terminal 258 of a nursing service and/or doctor B′, which can at least temporarily control or influence or monitor the operation of the device 100 remotely (from a distance).
  • IT information technology
  • the corresponding data connections which are preferably also IP (Internet Protocol)-based or generally packet data-based data connections, are in 8 with the arrows A13 (eg connection of the server 252 to the Internet 250 or the cloud), A14 (connection of the doctor's terminal 258 to the Internet 250 or the cloud), A15 (direct data connection between the server 252 and the doctor's Terminal 258, eg via a local area network (LAN) or private network (eg virtual private network, VPN)), A16 (connection of the doctor's terminal 258 via, for example, an LTE communication system 256).
  • IP Internet Protocol
  • a data communication (e.g. realized by the USB data connection between the interfaces 1106 ( figure 5 ), 1206 ( 6 )) between the primary control device 110 and the secondary control device 120 indicated by the arrow A8.
  • the USB data connection A8 can be used to periodically exchange data between the devices 110, 120, for example, in order to allow for a failure of at least one of the devices 110, 120 by the other device, for example after the absence of the data to be sent periodically for a predefinable waiting time.
  • further data can also be exchanged via the USB data connection A8.
  • the primary control device 110 can request new control information SI1, SI2 from the secondary control device 120 via the USB data connection A8, and the secondary control device 120 can send the new control information SI1, SI2 to the primary control device 110 via the USB data connection A8, etc .
  • the primary control device 110 ( 8 ) or 1100 ( figure 5 ) is designed to control the secondary control device 120 ( 8 ) or 1200 ( 6 ) via the at least one control interface 1108 ( figure 5 ) to reset (i.e. to reset), in particular to put it into a reset state.
  • a reset input not shown
  • the secondary control device 120 or its computing device 1102 ( figure 5 ) outputs.
  • software-related error states of the secondary control device can be ended and, in particular, a restart of the secondary control device 120 can be effected.
  • the primary control device 110 ( 8 ) or 1100 ( figure 5 ) is designed to switch the secondary control device 120, 1200 from a first operating state to a second operating state via the at least one control interface 1108, with the first operating state in particular being an energy-saving state (e.g. standby mode) and the second operating state being an active operating state.
  • the first operating state in particular being an energy-saving state (e.g. standby mode) and the second operating state being an active operating state.
  • a "wake-up signal” A10 via its control interface 1108 to an interrupt input of the secondary control device 120 or its computing device 1202 ( 6 ) outputs, as a result of which a corresponding interrupt request (interrupt) can be transmitted to the secondary control device 120 or its computing device 1202, which puts the secondary control device 120 into the active operating state.
  • the primary control device 110, 1100 is designed to periodically receive data A8 from the secondary control device 120, 1200 and to initiate a first error response if no data is received from the secondary control device 120 for a specifiable first waiting time , 1200 are received, wherein the first error reaction includes in particular a resetting or the resetting of the secondary control device.
  • the primary control device 110, 1100 is designed to switch the secondary control device 120, 1200, in particular repeatedly, more particularly periodically, from an energy-saving state to an active operating state. This makes it possible for the secondary control device 120, 1200 to be regularly put into an energy-saving state, as a result of which the electrical power consumption of the device is reduced. At the same time, the secondary control device 120, 1200 can be activated or woken up again by the primary control device 110, 1100 if required.
  • the primary control device 110, 1100 can then wake up the secondary control device 120, 1200 or activate it again from an energy-saving state if a function is required for the operation of the primary control device 110, 1100 or the device 100, 100a, 100b of the secondary controller 120, 1200 is required.
  • this can be the case in particular in the following exemplary situations: a) the data interface 1216 is required for communication with at least one external unit 250, 252, 258, for example to signal an error and/or new control information SI3 ( 8 ) from the external unit 250, 252, 258 (e.g.
  • an interaction with the user B is to be carried out (display of information on the display device 150, compare figure 7 , and/or audio output or audio input), c) new control data SI2 from the storage device 1204 of the secondary control device 1200 are to be retrieved or transmitted to the primary control device 1100.
  • the secondary control device 120, 1200 is designed to reset the primary control device 110, 1100 via the at least one control interface 1208. This can be done, for example, if there is an error or a malfunction in the operation of the primary control device 110, 1100. As a result, for example, software-related or firmware-related error states of the primary control device can be ended and, in particular, a restart of the primary control device 110, 1100 can be effected.
  • the secondary control device 120, 1200 is designed to periodically receive data A8 from the primary control device 110, 1100 (for example again via the USB interface 1106, 1206 already described above) and to initiate a second error response if no data is received from the primary control device 110, 1100 for a second, specifiable waiting time, with the second error response involving in particular a resetting of the primary control device 110 , 1100 includes.
  • the second waiting time can be at least approximately equal to the first waiting time. In further preferred embodiments, however, the second waiting time can also be larger or smaller than the first waiting time.
  • the secondary control device 120, 1200 is designed to a) operate at least one component 110, 1100, 180, 181, 104, 130, 132, 134, 140, 150, 160, 170 of the device 100, 100a, 100b and/or b) information characterizing an operating state of at least one component 110, 1100, 180, 181, 104, 130, 132, 134, 140, 150, 160, 170 of the device 100, 100a, 100b to send a or the external unit 250, 252, 258.
  • the device 100, 100a, 100b has a primary electrical power supply unit 180 and a secondary electrical power supply unit 181, with the primary electrical power supply unit 180 in particular being designed for connection to a power grid, in particular an AC power grid, with the secondary electrical power supply unit 181 in particular having at least one of the following elements includes: battery, accumulator, ultracapacitor (e.g. double-layer capacitor).
  • the primary electrical power supply unit 180 in particular being designed for connection to a power grid, in particular an AC power grid
  • the secondary electrical power supply unit 181 in particular having at least one of the following elements includes: battery, accumulator, ultracapacitor (e.g. double-layer capacitor).
  • the secondary electrical energy supply unit 181 is designed to at least temporarily supply at least some components of the device with electrical energy, with the secondary electrical energy supply unit 181 in particular being designed to at least temporarily supply at least the primary control device 110, 1100 and to supply the transport device 132 with electrical energy. This advantageously ensures that operation of the device 100, 100a, 100b for dispensing medication can be maintained even in the event of a fault in the primary electrical energy supply unit 180 or in the mains supply feeding it.
  • the device 100, 100a, 100b is designed to detect a fault and/or a failure of the power grid and from a first operating mode in which the device 100, 100a, 100b is powered by the primary electrical energy supply unit 180 can be supplied by the power grid to switch to a second operating mode, in which case at least some components of the device 100, 100a, 100b can be supplied with electrical energy by means of the secondary electrical energy supply unit 181 in the second operating mode.
  • figure 9 shows an example of a simplified state diagram with the first operating mode BA1, the first operating mode BA1 corresponding, for example, to a properly operating mains power supply of the device by means of the primary electrical energy supply unit 180, and the second operating mode BA2 corresponding to battery operation, for example, in which the device 100, 100a , 100b is operated by means of the secondary electrical energy supply unit 181, in particular using workable electrical charge stored at least temporarily in at least one "electrical energy store" (for example accumulator and/or battery and/or supercapacitor or any combination thereof) of the secondary electrical energy supply unit 181.
  • the secondary electrical energy supply unit 181 in particular using workable electrical charge stored at least temporarily in at least one "electrical energy store" (for example accumulator and/or battery and/or supercapacitor or any combination thereof) of the secondary electrical energy supply unit 181.
  • electrical energy store for example accumulator and/or battery and/or supercapacitor or any combination thereof
  • a first state transition T12 from the first operating mode BA1 to the second operating mode BA2 occurs, for example, when a mains power supply fails, and a second state transition T21 from the second operating mode BA2 to the first operating mode BA1 occurs, for example, when a mains power supply fails after a previous failure is recovered.
  • chargeable electrical energy stores of the secondary electrical energy supply unit 181 can be (re)charged in the first operating mode BA1.
  • the state transitions T12, T21 between the different operating modes BA1, BA2 or a monitoring of the electrical energy supply by the components 180, 181 can be controlled or executed either by the primary control device 110, 1100 or by the secondary control device 120, 1200 become.
  • the control of the state transitions and/or the monitoring of the components 180, 181 or their electrical energy supply is carried out both by the primary control device 110 , 1100 and also by the secondary control device 120, 1200, for example using a redundancy principle.
  • the control device(s) 110, 120, 1100, 1200 can be controlled accordingly, for example by the functionality of the first computer program PRG1 and/or the second computer program PRG2.
  • the device 100, 100a, 100b is designed to signal the disruption and/or failure of the power grid to at least one external unit 250, 252, 258.
  • the device 100, 100a, 100b is designed to, depending on the first control information Si1 ( figure 5 ) and/or the second control information SI2 ( 6 ) to determine future output times AZP1, AZP2, AZP3, AZP4 at which drugs 200b ( 4 ), for example in the form of one or more blister bags, to be dispensed by the device 100, 100a, 100b.
  • This is shown schematically in the timing diagram figure 10 shown.
  • the device 100, 100a, 100b is in the first operating mode BA1 (for example mains operation) at the time t0.
  • the second operating mode BA2 ( 9 ) (e.g. battery operation or accumulator operation) changes.
  • Device 100, 100a, 100b determines, as already described above, depending on first control information SI1 ( figure 5 ) and/or the second control information SI2 ( 6 ) the future issue times AZP1, AZP2, AZP3, AZP4 at which the drugs 200b ( 4 ) are to be output by the device 100, 100a, 100b. The determination takes place, for example, immediately after the power failure, or shortly thereafter, for example at the point in time t2>t1.
  • the first output time AZP1 determined in this way corresponds to time t3>t2, the second output time AZP2 to time t4>t3, the third output time AZP3 to time t5>t4, and the fourth output time AZP4 to time t6>t5.
  • the device 100, 100a, 100b is designed to set a minimum remaining operating time BDmin of the device 100, 100a, 100b in the second operating mode BA2 ( 9 ) to be determined, whereby the future issue times are taken into account in particular.
  • the device 100, 100a, 100b takes into account, in particular, a possibly increased electrical energy consumption for the relevant output times (compared to an energy-saving state, for example caused by the operation of the transport device 132). For example, if a comparatively large number of output times has been determined, the minimum remaining operating time BDmin will turn out to be comparatively small compared to another application example in which a comparatively small number of output times for battery operation has been determined.
  • the further operation of the device 100, 100a, 100b can be controlled particularly precisely, in particular with the aim of ensuring an uninterrupted or as long as possible proper supply of the user B with his medication 200b.
  • the determination of the output times or the minimum remaining operating time BDmin can also be carried out by primary control device 110 and/or by secondary control device 120.
  • the device 100, 100a, 100b is designed to have a first number N1 ( 8 ) that characterizes for how many of the future output times operation of the device can be maintained in the second operating mode BA2.
  • N1 8
  • the device 100, 100a, 100b is designed to have a first number N1 ( 8 ) that characterizes for how many of the future output times operation of the device can be maintained in the second operating mode BA2.
  • N1 8
  • the device 100, 100a, 100b is designed to have a first number N1 ( 8 ) that characterizes for how many of the future output times operation of the device can be maintained in the second operating mode BA2.
  • N1 8
  • the device 100, 100a, 100b is designed to output the minimum remaining operating time BDmin and/or the first number N1 to a user B of the device 100, 100a, 100b (for example via the display device 150 or a corresponding graphical user interface and/or in the form of an audio signal, for example a voice output or a signal tone, or by means of combinations thereof) and/or to at least one external unit 250, 252, 258.
  • a user B of the device 100, 100a, 100b for example via the display device 150 or a corresponding graphical user interface and/or in the form of an audio signal, for example a voice output or a signal tone, or by means of combinations thereof
  • the user B and/or a nursing service or medical staff B' can efficiently be informed of the possibly critical operating situation and a possible impending shortage (e.g. if the power failure persists beyond time t5) of medication, so that countermeasures can be taken in good time can be initiated.
  • the device 100, 100a, 100b is designed to determine whether the minimum remaining operating time BDmin allows medication to be dispensed for a predefinable second number N2 of dispensing times of the future dispensing times.
  • the predefinable second number N2 can be configured or parameterized, for example, and can also be predeter- mined or selected depending on the medication to be dispensed or the medication plan.
  • N3> 4) of future dispensing times to dispense medication corresponding to an unscheduled dispensing of medication before these future dispensing times AZP1, AZP2, AZP3, AZP4, in particular within the minimum remaining operating time BDmin, in particular immediately after it has been determined that the minimum remaining operating time BDmin no longer allows medication to be dispensed for the predefinable second number N2 of dispensing times.
  • the unscheduled dispensing of medication can take place directly after the aforementioned evaluation, for example shortly after time t2.
  • the device 100, 100a, 100b is designed to receive a release for the unscheduled dispensing of medication from an external unit 250, 252, 258 and/or a user B' of the external unit 258 ( doctor's terminal).
  • a treating or caring doctor B 'for example the current operating situation Device are signaled, preferably together with the request for approval for the unscheduled drug delivery, whereupon the doctor B 'make an appropriate decision and grant or deny the approval.
  • the unscheduled dispensing of medication can take place as described above by way of example.
  • the entire stock of medication in the reservoir 130 of the device 100, 100a, 100b can also be dispensed, for example as a precaution in the event of a prolonged interruption in the electrical power supply of the device.
  • the attending doctor B' refuses the unscheduled dispensing of medication, corresponding information can be output to the user B of the device 100, 100a, 100b, for example again in a visually perceptible form via the display device 150 and/or by means of a Speech output, compare unit 160 and/or a combination of the above measures.
  • the information to user B can also include further information in this case, for example about alternative remedial measures that the attending physician B' may have initiated (e.g. sending a nursing service to user B or to device 100, 100a , 100b, e.g. for maintenance).
  • the device 100, 100a, 100b is designed to, in the second operating mode BA2 ( 9 ) to put at least one component of the device into a power-saving state or to deactivate it.
  • the second operating mode BA2 all components of the device that are not absolutely necessary for the secure dispensing of medication at future dispensing times (for example components that enable comfort functions such as the output of a time on the display device 150) are particularly preferably deactivated or put into an energy-saving state and/or communication via the interface 1216 and/or other electrical consumers).
  • the primary control device 110 is put into an energy-saving state. In further preferred embodiments it is provided that the primary control device 110 has a maximum electrical power consumption of 60 mW (milliwatts) in this energy-saving state, in particular 50 mW or less.
  • an electrical capacitance of the secondary electrical energy supply unit 181 (or its storage devices such as batteries or accumulators, for example, in relation to two supercapacitors) ( 1 ) is so great that the minimum remaining operating time BDmin is at least about 12 hours, preferably at least about 24 hours.
  • the electrical storage capacity the future dispensing times that are dependent on a given medication plan and, associated therewith, at least part-time operation of the transport device 132 can advantageously be taken into account.
  • a or the electrical capacity of the secondary electrical energy supply unit 181 is at least approximately 2000 milliampere hours (mAh), in particular at least 3000 mAh at a preferably 15 volt nominal voltage.
  • FIG. 1 shows a simplified flow chart according to preferred embodiments
  • the primary control device 110, 1100 controls at least the first component K1 of the device 100, 100a, 100b
  • the secondary control device 120, 1200 controls at least the second component K2 of the device 100, 100a, 100b
  • the device 100, 100a, 100b dispenses medication, preferably in the form of one or more blister bags, to the user B at dispensing times selected as a function of control information SI1 and/or SI2 and/or SI3.
  • the transport device 132 ( figure 4 ) controlled by the primary control device 110, 1100.
  • the primary control device 110 at least temporarily stores the first control information SI1, see step 310, the first control information having in particular administration information characterizing administration times of medication and/or medication or medication information characterizing the medication.
  • the primary control device 110 controls the transport device 132 depending on the first control information SI1.
  • the first control information SI1 contains further information PI, M1 that enable the primary control device 110 and/or the secondary control device 120 to determine future dispensing times for medication to be dispensed by means of the device 100, 100a, 100b.
  • the secondary control device 120 at least temporarily stores the second control information SI2, compare step 320, the second control information SI2 having in particular administration information characterizing administration times of medicines and/or medicines or medicine information characterizing the medicines.
  • the second control information SI2 or at least parts thereof can be transmitted to the primary control device 110, for example via a USB interface A8 (compare also the elements 1106, 1206 from figure 5 , 6 ).
  • the primary control device 110 periodically receives data from the secondary control device 120, see step 330, and initiates a first error reaction, see step 332, if no data is received from the secondary control device for a predeterminable first waiting time, the first Error reaction includes in particular a resetting of the secondary control device 120 .
  • the primary control device 110 can control the transport device 132 autonomously, i.e. in particular without a data connection that may exist to the secondary control device 120 and/or without the involvement of the secondary control device 120. This advantageously ensures that the primary control device 110 is at least temporarily can maintain the operation of the device 100, 100a, 100b for dispensing medication even in the event of malfunctions of the secondary control device 120 alone.
  • the secondary control device 120 periodically receives data from the primary control device 110, cf. step 340, and initiates a second error reaction, step 342, if no data is received from the primary control device 110 for a specifiable second waiting time, the second Error reaction includes in particular a resetting of the primary control device 110 .
  • step 344 it can be provided in optional step 344 that the error state of primary control device 110 detected in step 342 is signaled to at least one external unit 250, 252, 258.
  • the secondary control device 120--in contrast to the primary control device 110--does not trigger the transport device 132 and thus cannot cause medication to be dispensed because the error state is escalated by the signaling according to step 344, as a result of which countermeasures can be introduced efficiently.
  • the secondary control device 120 in which the secondary control device 120 can also directly trigger the transport device 132 itself, the same procedure can be used, ie a signaling according to step 344 can be carried out.
  • the secondary control device 120 can be operated independently at least temporarily and, in particular, can be operated in such a way that it controls the transport device 132 in order to cause medication to be dispensed, in particular during the failure of the primary control device 110.
  • the secondary control device a) monitors operation of at least one component of device 100, 100a, 100b, step 350, and/or b) transmits information characterizing an operating state of at least one component of device 100, 100a, 100b to one or the external unit 250, 252, 258 sends, see step 352.
  • secondary control device 120 can use its data connection to the at least one external unit 250, 252, 258 to receive third control information SI3 from external unit 250, 252, 258, on the basis of which device 100, 100a, 100b generates second control information SI2 and determines or forms the first control information SI1, which controls the operation of the primary control device 110 with regard to the activation of the transport device 132 and thus the dispensing of medication.
  • steps 354, 356 can be carried out after 16 can also be carried out independently, i.e. in particular without the 16 previous steps 350, 352.
  • FIG 17 shows schematically a simplified flow chart of a method according to further preferred embodiments.
  • the device 100, 100a, 100b has its first operating mode BA1 ("mains operation")
  • the device 100, 100a, 100b switches on, for example due to a power failure of a power grid that the device is connected to its second operating mode BA2 ("battery operation")
  • the optional step 364 the device 100, 100a, 100b changes from the second operating mode BA2 back to the first operating mode BA1 because the mains power supply has been restored .
  • step 364 for example, an accumulator of the secondary electrical energy supply unit 181 ( 1 ) to be recharged.
  • figure 18 shows schematically a simplified flow chart of a method according to further preferred embodiments.
  • the device 100, 100a, 100b detects a failure of the power grid and then changes in step 372 from its first operating mode BA1 to its second operating mode BA2.
  • the device 100, 100a, 100b signals the disruption and/or failure of the power grid to at least one external unit 250, 252, 258 ( 8 ) and/or the user B.
  • FIG 19 shows schematically a simplified flow chart of a method according to further preferred embodiments.
  • Device 100, 100a, 100b determines, cf. step 380, future output times AZP1, AZP2, AZP3, .. ( 10 ) for which medication is to be dispensed by the device 100, 100a, 100b.
  • this can preferably be done by the primary control device 110, for example under the control of the first computer program PRG1.
  • the secondary control device 120 for example under the control of the second computer program PRG2.
  • a redundant execution of step 380 by both control devices 110, 120 is also conceivable.
  • step 382 the device 100, 100a, 100b determines a or the minimum remaining operating time BDmin ( 10 ) of the device in the second operating mode BA2, with future dispensing times AZP1, AZP2, AZP3, . .
  • step 382 can preferably be carried out by the primary control device 110, for example under the control of the first computer program PRG1.
  • step 382 can also be executed by the secondary control device 120, for example under the control of the second computer program PRG2.
  • a redundant execution of step 382 by both control devices 110, 120 is also conceivable.
  • the device 100, 100a, 100b determines a first number N1, see step 390, which characterizes how many of the future output times an operation of the device 100, 100a, 100b can be maintained in the second operating mode BA2, where in particular the device 100, 100a, 100b outputs the minimum remaining operating time BDmin to a user B of the device 100, 100a, 100b and/or signals it to at least one external unit 250, 252, 258, cf. the optional step 392, and/or outputs the first number N1 to a user B of the device 100, 100a, 100b and/or signals it to at least one external unit 250, 252, 258, cf. the further optional step 394.
  • FIG 21 shows schematically a simplified flow chart of a method according to further preferred embodiments.
  • the device 100, 100a, 100b is in its second operating mode BA2.
  • the device 100, 100a, 100b determines whether the minimum remaining operating time BDmin allows medication to be dispensed for a predeterminable second number N2 of dispensing times of the future dispensing times, with the device 100, 100a, 100b in particular then when the minimum remaining Operating time BDmin one no longer permits dispensing of medication for a predeterminable second number of dispensing times of the future dispensing times, dispenses medication corresponding to a predeterminable third number of future dispensing times as part of an unscheduled dispensing of medication before these future dispensing times, in particular within the minimum remaining operating time, more particularly immediately after it has been determined is that the minimum remaining operating time no longer allows medication to be dispensed for the predefinable second number of dispensing times, cf. optional step 404.
  • figure 22 shows schematically a simplified flow chart of a method according to further preferred embodiments. Steps 400, 402 correspond to the corresponding steps in FIG figure 21 .
  • figure 21 fetches the device in accordance with the method figure 22 in step 403 before the unscheduled drug delivery, compare step 404 ⁇ figure 22 , a release for the unscheduled medication delivery 404 ⁇ from an external unit 250, 252, 258 and/or a user B' of the external unit 258. If the release is granted, the unscheduled dispensing of medication takes place in step 404'.
  • Further preferred embodiments relate to the use of at least one device 100, 100a, 100b according to the embodiments and/or the method according to the embodiments for dispensing medication 200b, in particular to a user B, and/or for the care of one or more persons B with medicaments, in particular for the supply of medicaments to persons located at several different geographical locations.
  • the principle according to the embodiments enables a particularly safe and reliable operation of the device, in particular even when some components of the device fail at least temporarily or their operation is restricted in some other way.
  • an emergency operation for the regulated dispensing of medication can be maintained, preferably under the control of the primary control device 110, in particular even when the secondary control device 120 is not working or is not working properly.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (25)

  1. Dispositif (100; 100a; 100b) de distribution de médicaments, dans lequel le dispositif (100; 100a; 100b) comprend un dispositif de commande primaire (110; 1100) destiné à commander au moins un premier composant (K1) du dispositif (100; 100a; 100b) ainsi qu'un dispositif de commande secondaire (120; 1200) destiné à commander au moins un deuxième composant (K2) du dispositif (100; 100a; 100b), dans lequel le dispositif est conçu pour distribuer des médicaments (210a, 210b, 211a, 212a , 212b, 212c) disposés dans des sachets blisters (210, 211, 212), dans lequel en particulier le dispositif (100; 100a; 100b) comprend un réservoir de stockage (130) pour des médicaments à distribuer, en particulier des sachets blisters, ainsi qu'un dispositif de transport (132) pour transporter les médicaments, en particulier les sachets blisters, hors du réservoir de stockage (130), dans lequel le dispositif de commande primaire (110; 1100) est conçu pour recevoir périodiquement des données du dispositif de commande secondaire (120; 1200) et pour initier une première réaction d'erreur si on n'a pas reçu des données du dispositif de commande secondaire (120; 1200) pendant un premier temps d'attente prédéterminable.
  2. Dispositif (100; 100a; 100b) selon la revendication 1, dans lequel le dispositif de commande primaire (110; 1100) est conçu pour stocker au moins temporairement des premières informations de commande (SI1), dans lequel les premières informations de commande (SI1) comprennent des informations d'administration (EI) de médicaments caractérisant des instants d'administration et/ou des informations de médicament (MI) caractérisant des médicaments ou bien les médicaments.
  3. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, a) dans lequel le dispositif de commande primaire (110; 1100) comprend une première interface de données (1106) pour l'échange de données (A4) de préférence bidirectionnel avec au moins le dispositif de commande secondaire (120; 1200), dans lequel en particulier la première interface de données (1106) présente une interface de données série, de préférence du type Universal Serial Bus, USB, et/ou b) dans lequel le dispositif de commande secondaire (120; 1200) présente une première interface de données (1206) pour l'échange de données de préférence bidirectionnel avec au moins le dispositif de commande primaire (110; 1100), dans lequel, en outre, en particulier la première interface de données (1206) présente une interface de données série, de préférence de type Universal Serial Bus, USB.
  4. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel
    A) le dispositif de commande primaire (110; 1100) comprend au moins une interface de commande (1108) agissant sur le dispositif de commande secondaire (120; 1200), dans lequel le dispositif de commande primaire (110; 1100) est conçu
    Aa) pour réinitialiser le dispositif de commande secondaire (120; 1200) via ladite au moins une interface de commande (1108), en particulier pour le faire passer dans un état de réinitialisation, en anglais: reset, et/ou
    Ab) pour faire passer le dispositif de commande secondaire (120; 1200) via ladite au moins une interface de commande (1108) d'un premier état de fonctionnement à un deuxième état de fonctionnement, dans lequel en particulier le premier état de fonctionnement est un état d'économie d'énergie et le deuxième état de fonctionnement est un état de fonctionnement actif, et/ou dans lequel
    B) le dispositif de commande secondaire (120; 1200) comprend au moins une interface de commande (1208) agissant sur le dispositif de commande primaire (110; 1100), dans lequel en particulier le dispositif de commande secondaire (120; 1200) est conçu pour réinitialiser le dispositif de commande primaire (110; 1100) via ladite au moins une interface de commande (1108), en particulier pour le faire passer dans un état de réinitialisation, en anglais: reset.
  5. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel la première réaction d'erreur comprend en particulier une ou bien la réinitialisation du dispositif de commande secondaire (120; 1200) et/ou dans lequel le dispositif de commande secondaire (120; 1200) est conçu pour recevoir périodiquement des données du dispositif de commande primaire (110; 1100) et pour initier une deuxième réaction d'erreur si on n'a pas reçu des données du dispositif de commande primaire (110; 1100) pendant un deuxième temps d'attente prédéterminable, la deuxième réaction d'erreur comprenant en particulier une ou bien la réinitialisation du dispositif de commande primaire (110; 1100).
  6. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel le dispositif de commande primaire (110; 1100) est conçu pour commander le dispositif de transport (132) de manière autarcique, en particulier sans la participation du dispositif de commande secondaire (120; 1200), en particulier en fonction des premières informations de commande (SI1).
  7. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel
    A) le dispositif de commande secondaire (120; 1200) comprend au moins l'un des éléments suivants: une interface (1210) pour commander un ou bien le dispositif d'affichage (150), une interface (1212) pour commander un ou bien le dispositif (160) de sortie et/ou d'entrée de signaux acoustiques, une interface (1214) pour commander un ou bien le dispositif d'acquisition d'images numérique (170), au moins une interface de données (1216) pour établir une connexion de données avec au moins une unité externe (250), en particulier un serveur (252) et/ou un système de serveur cloud (250), et/ou dans lequel
    B) le dispositif de commande secondaire (110; 1100) est conçu pour
    Ba) surveiller un fonctionnement d'au moins un composant (110, 120, 130, 132, 134, 140, 150, 160, 170) du dispositif (100; 100a; 100b) et/ou
    Bb) envoyer des informations caractérisant un état de fonctionnement d'au moins un composant (110, 120, 130, 132, 134, 140, 150, 160, 170) du dispositif (100; 100a; 100b), à une ou bien ladite unité externe (250, 252, 258), et/ou dans lequel
    C) le dispositif de commande secondaire (120; 1200) est conçu pour mémoriser au moins temporairement des deuxièmes informations de commande (SI2), dans lequel les deuxièmes informations de commande (SI2) présentent en particulier des informations d'administration (EI') de médicaments caractérisant des instants d'administration et/ou des informations de médicament (MI') caractérisant des médicaments ou bien les médicaments.
  8. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel le dispositif (100; 100a; 100b) est conçu pour recevoir des troisièmes informations de commande (SI3) d'une unité externe (250, 252, 258) et pour commander le fonctionnement d'au moins un composant (K1, K2) du dispositif (100; 100a; 100b) en fonction des troisièmes informations de commande (SI3), dans lequel en particulier le dispositif (100; 100a; 100b) est conçu pour effectuer la distribution de médicaments en fonction des troisièmes informations de commande (SI3).
  9. Dispositif (100; 100a; 100b) selon au moins l'une des revendications précédentes, dans lequel le dispositif (100; 100a; 100b) comprend une unité primaire d'alimentation en énergie électrique (180) et une unité secondaire d'alimentation en énergie électrique (181), dans lequel en particulier l'unité primaire d'alimentation en énergie électrique (180) est conçue pour être raccordée à un réseau électrique, en particulier un réseau électrique à courant alternatif, dans lequel en particulier l'unité secondaire d'alimentation en énergie électrique (181) comprend au moins l'un des éléments suivants: batterie, accumulateur, ultracondensateur, dans lequel en particulier l'unité secondaire d'alimentation en énergie électrique (181) est conçue alimenter au moins temporairement en énergie au moins certains composants du dispositif (100; 100a; 100b), dans lequel en particulier l'unité secondaire d'alimentation en énergie électrique (181) est conçue pour alimenter en énergie électrique au moins le dispositif de commande primaire (110; 1100) et le dispositif de transport (132) .
  10. Dispositif (100; 100a; 100b) selon la revendication 9, dans lequel le dispositif (100; 100a; 100b) est conçu pour détecter une perturbation et/ou une panne du réseau électrique et pour passer d'un premier mode de fonctionnement (BA1) dans lequel le dispositif (100; 100a; 100b) peut être alimenté par le réseau électrique au moyen de l'unité primaire d'alimentation en énergie électrique (180), à un deuxième mode de fonctionnement (BA2), dans lequel, dans le deuxième mode de fonctionnement (BA2), au moins certains composants du dispositif (100; 100a; 100b) peuvent être alimentés en énergie électrique par l'intermédiaire de l'unité secondaire d'alimentation en énergie électrique (181), dans lequel en particulier le dispositif (100; 100a; 100b) est conçu pour signaler la perturbation et/ou la panne du réseau électrique à au moins une unité externe (250, 252, 258).
  11. Dispositif (100; 100a; 100b) selon au moins l'une des revendications 2 à 10, dans lequel le dispositif (100; 100a; 100b) est conçu pour déterminer, en fonction des premières informations de commande (SI1) et/ou des deuxièmes informations de commande (SI2) et/ou des troisièmes informations de commande (SI3), des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) auxquels des médicaments doivent être distribués par le dispositif (100; 100a; 100b).
  12. Dispositif (100; 100a; 100b) selon au moins l'une des revendications 10 à 11, dans lequel le dispositif (100; 100a; 100b) est conçu pour déterminer une durée de fonctionnement restant au minimum (BDmin) du dispositif (100; 100a; 100b) dans le deuxième mode de fonctionnement (BA2), les futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) étant en particulier pris en compte à cet effet, dans lequel en particulier le dispositif (100; 100a; 100b) est conçu pour fournir la durée de fonctionnement restant au minimum (BDmin) à un utilisateur (B) du dispositif (100; 100a; 100b) et/ou pour le signaler à au moins une unité externe (250, 252, 258).
  13. Dispositif (100; 100a; 100b) selon au moins l'une des revendications 11 à 12, dans lequel le dispositif (100; 100a; 100b) est conçu pour déterminer un premier nombre (N1) qui caractérise le nombre de futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) pour lequel un fonctionnement du dispositif (100; 100a; 100b) dans le deuxième mode de fonctionnement (BA2) peut être maintenu, dans lequel en particulier le dispositif (100; 100a; 100b) est conçu pour fournir le premier nombre (N1) à un utilisateur (B) du dispositif (100; 100a; 100b) et/ou pour le signaler à au moins une unité externe (250, 252, 258).
  14. Dispositif (100; 100a; 100b) selon au moins l'une des revendications 12 à 13, dans lequel le dispositif (100; 100a; 100b) est conçu pour déterminer si la durée de fonctionnement restant au minimum (BDmin) permet une distribution de médicaments pour un deuxième nombre prédéterminable (N2) d'instants de distribution (AZP1, AZP2, AZP3) des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), dans lequel
    en particulier le dispositif (100; 100a; 100b) est conçu pour, lorsque la durée de fonctionnement restant au minimum (BDmin) ne permet plus une distribution de médicaments pour un deuxième nombre (N2) prédéterminable d'instants de distribution (AZP1, AZP2, AZP3) des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), distribuer des médicaments correspondant à un troisième nombre (N3) prédéterminable de futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), dans le cadre d'une distribution imprévue de médicaments avant ces futurs instants de distribution (AZP1, AZP2, AZP3, AZP4),
    en particulier dans la durée de fonctionnement restant au minimum (BDmin),
    en outre, en particulier immédiatement après qu'il a été déterminé que la durée de fonctionnement restant au minimum (BDmin) ne permet plus la distribution de médicaments pour le deuxième nombre (N2) prédéterminable d'instants de distribution (AZP1, AZP2, AZP3), dans lequel en particulier le dispositif (100; 100a; 100b) est conçu pour demander, avant la distribution imprévue de médicament, d'une unité externe (250, 252, 258) et/ou d'un utilisateur (B') de l'unité externe (250, 252, 258) une libération pour la distribution imprévue de médicament.
  15. Procédé destiné à faire fonctionner un dispositif (100; 100a; 100b) de distribution de médicaments disposés dans des sachets blisters, en particulier un dispositif selon au moins l'une des revendications précédentes, dans lequel le dispositif (100; 100a; 100b) comprend un dispositif de commande primaire (110; 1100) destiné à commander au moins un premier composant (K1) du dispositif (100; 100a; 100b) ainsi qu'un dispositif de commande secondaire (120; 1200) destiné à commander au moins un deuxième composant (K2) du dispositif (100; 100a; 100b), dans lequel le dispositif de commande primaire (110; 1100) commande (300) ledit au moins un premier composant (K1), et dans lequel le dispositif de commande secondaire (120; 1200) commande (302) ledit au moins un deuxième composant (K2), dans lequel en particulier le dispositif (100; 100a; 100b) comprend un dispositif de transport (132) pour transporter les sachets blisters, en particulier hors d'un réservoir de stockage (130), et dans lequel en particulier le dispositif de commande primaire (110; 1100) commande (312) le dispositif de transport (132) pour transporter les médicaments, en particulier sachets blisters, dans lequel le dispositif de commande primaire (110; 1100) reçoit (330) périodiquement des données du dispositif de commande secondaire (120; 1200) et initie (332) une première réaction d'erreur si on n'a pas reçu des données du dispositif de commande secondaire (120; 1200) pendant un premier temps d'attente prédéterminable.
  16. Procédé selon la revendication 15, dans lequel le dispositif de commande primaire (110; 1100) mémorise (310) au moins temporairement des premières informations de commande (SI1), dans lequel les premières informations de commande (SI1) présentent en particulier des informations d'administration (EI) de médicaments caractérisant des instants d'administration et/ou des informations de médicament (MI) caractérisant des médicaments ou bien les médicaments, dans lequel en particulier le dispositif de commande secondaire (120; 1200) mémorise (320) au moins temporairement des deuxièmes informations de commande (SI2), dans lequel les deuxièmes informations de commande (SI2) présentent en particulier des d'informations d'administration (EI') de médicaments caractérisant des instants d'administration et/ou des informations de médicament (MI') caractérisant des médicaments ou bien les médicaments.
  17. Procédé selon au moins l'une des revendications 15 à 16, dans lequel le dispositif de commande primaire (110; 1100) comprend une première interface de données (1106) pour l'échange de données de préférence bidirectionnel avec au moins le dispositif de commande secondaire (120; 1200), dans lequel en outre en particulier la première interface de données (1106) présente une interface de données série, de préférence du type Universal Serial Bus, USB, dans lequel en particulier le dispositif de commande primaire (110; 1100) présente au moins une interface de commande (1108) agissant sur le dispositif de commande secondaire (120; 1200), dans lequel le dispositif de commande primaire (110; 1100) a) réinitialise le dispositif de commande secondaire (120; 1200) via ladite au moins une interface de commande (1108), en particulier le fait passer dans un état de réinitialisation, en anglais: reset, et/ou b) fait passer celui-ci, via ladite au moins une interface de commande (1108), d'un premier état de fonctionnement à un deuxième état de fonctionnement, dans lequel en particulier le premier état de fonctionnement est un état d'économie d'énergie et le deuxième état de fonctionnement est un état de fonctionnement actif.
  18. Procédé selon au moins l'une des revendications 15 à 17, dans lequel la première réaction d'erreur comprend une ou bien la réinitialisation du dispositif de commande secondaire (120; 1200).
  19. Procédé selon au moins l'une des revendications 15 à 18, dans lequel le dispositif de commande primaire (110; 1100) commande (312; 334) le dispositif de transport (132) de manière autarcique, au moins temporairement, en particulier sans la participation du dispositif de commande secondaire (120; 1200).
  20. Procédé selon au moins l'une des revendications 15 à 19, dans lequel
    A) le dispositif de commande secondaire (120; 1200) présente une première interface de données (1206) pour l'échange de données de préférence bidirectionnel avec au moins le dispositif de commande primaire (110; 1100),
    B) dans lequel, en outre, en particulier la première interface de données (1206) présente une interface de données série, de préférence du type Universal Serial Bus, USB,
    C) dans lequel en particulier le dispositif de commande secondaire (120; 1200) présente au moins une interface de commande (1208) agissant sur le dispositif de commande primaire (110; 1100),
    D) dans lequel en particulier le dispositif de commande secondaire (120; 1200) réinitialise le dispositif de commande primaire (110; 1100) via ladite au moins une interface de commande (1208), en particulier fait passer celui-ci dans un état de réinitialisation, et/ou
    E) le dispositif de commande secondaire (120; 1200) reçoit (340) périodiquement des données du dispositif de commande primaire (110; 1100) et initie (342) une deuxième réaction d'erreur si l'on n'a pas reçu des données du dispositif de commande primaire (110; 1100) pour un deuxième temps d'attente prédéterminable,
    F) dans lequel la deuxième réaction d'erreur comprend en particulier une ou bien la réinitialisation du dispositif de commande primaire (110; 1100), et/ou dans lequel en particulier
    G) le dispositif de commande secondaire (110; 1100)
    G1) surveille (350) un fonctionnement d'au moins un composant (110, 120, 130, 132, 134, 140, 150, 160, 170) du dispositif (100; 100a; 100b) et/ou
    G2) envoie des informations caractérisant un état de fonctionnement d'au moins un composant (110, 120, 130, 132, 134, 140, 150, 160, 170) du dispositif (100; 100a; 100b), à une ou bien ladite unité externe (250, 252, 258), et/ou
    G3) le dispositif (100; 100a; 100b) reçoit (354) des troisièmes informations de commande (SI3) d'une unité externe (250, 252, 258) et commande (356) un fonctionnement d'au moins un composant (K1, K2) du dispositif (100; 100a; 100b) en fonction des troisièmes informations de commande (SI3), dans lequel en particulier le dispositif (100; 100a; 100b) effectue la distribution de médicaments en fonction des troisièmes informations de commande (SI3).
  21. Procédé selon au moins l'une des revendications 15 à 20, dans lequel le dispositif (100; 100a; 100b) comprend une unité primaire d'alimentation en énergie électrique (180) et une unité secondaire d'alimentation en énergie électrique (181), dans lequel en particulier l'unité primaire d'alimentation en énergie électrique (180) est conçue pour être raccordée à un réseau électrique, en particulier un réseau électrique à courant alternatif, dans lequel en particulier l'unité secondaire d'alimentation en énergie électrique (181) comprend au moins l'un des éléments suivants: batterie, accumulateur, ultracondensateur, dans lequel l'unité secondaire d'alimentation en énergie électrique (181) alimente au moins temporairement en énergie électrique au moins certains composants du dispositif (100; 100a; 100b), dans lequel en particulier l'unité secondaire d'alimentation en énergie électrique (181) alimente en énergie électrique au moins le dispositif de commande primaire (110; 1100) et le dispositif de transport (132) .
  22. Procédé selon la revendication 21, dans lequel le dispositif (100; 100a; 100b) détecte une perturbation et/ou une panne du réseau électrique et passe (372) d'un premier mode de fonctionnement (BA1) dans lequel le dispositif (100; 100a; 100b) peut être alimenté par le réseau électrique au moyen de l'unité primaire d'alimentation en énergie électrique (180), à un deuxième mode de fonctionnement (BA2), dans lequel, dans le deuxième mode de fonctionnement (BA2), au moins certains composants du dispositif (100; 100a; 100b) sont alimentés en énergie électrique par l'intermédiaire de l'unité secondaire d'alimentation en énergie électrique (181), dans lequel en particulier le dispositif (100; 100a; 100b) signale la perturbation et/ou la panne du réseau électrique à au moins une unité externe (250, 252, 258).
  23. Procédé selon au moins l'une des revendications 16 à 22, dans lequel le dispositif (100; 100a; 100b) détermine (380), en fonction des premières informations de commande (SI1) et/ou des deuxièmes informations de commande (SI2), des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) auxquels des médicaments doivent être distribués par le dispositif (100; 100a; 100b) .
  24. Procédé selon au moins l'une des revendications 22 à 23, dans lequel le dispositif (100; 100a; 100b) détermine (382) une durée de fonctionnement restant au minimum (BDmin) du dispositif (100; 100a; 100b) dans le deuxième mode de fonctionnement (BA2), dans lequel en particulier les futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) sont pris en compte à cet effet, dans lequel en particulier le dispositif (100; 100a; 100b) détermine (390) un premier nombre ( N1) qui caractérise le nombre des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4) pour lequel un fonctionnement du dispositif (100; 100a; 100b) dans le deuxième mode de fonctionnement (BA2) peut être maintenu, dans lequel en particulier le dispositif (100; 100a; 100b) fournit (392) la durée de fonctionnement restant au minimum (BDmin) et/ou le premier nombre (N1) à un utilisateur (B) du dispositif (100; 100a; 100b) et/ou signale (394) ceux-ci à au moins une unité externe (250, 252, 258), dans lequel en particulier le dispositif (100; 100a; 100b) détermine (402) si la durée de fonctionnement restant au minimum (BDmin) permet une distribution de médicaments pour un deuxième nombre (N2) prédéterminable d'instants de distribution (AZP1, AZP2, AZP3) des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), dans lequel en particulier le dispositif (100; 100a; 100b), lorsque la durée de fonctionnement restant au minimum (BDmin) ne permet plus une distribution de médicaments pour un deuxième nombre (N2) prédéterminable d'instants de distribution (AZP1, AZP2, AZP3) des futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), distribue (404; 404') des médicaments correspondant à un troisième nombre (N3) prédéterminable de futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), dans le cadre d'une distribution imprévue de médicaments avant ces futurs instants de distribution (AZP1, AZP2, AZP3, AZP4), en particulier pendant la durée de fonctionnement restant au minimum (BDmin), en outre en particulier immédiatement après qu'il a été déterminé que la durée de fonctionnement restant au minimum (BDmin) ne permet plus une distribution de médicaments pour le deuxième nombre (N2) prédéterminable d'instants de distribution (AZP1, AZP2, AZP3), dans lequel en particulier le dispositif (100; 100a; 100b) demande, avant la distribution imprévue de médicaments (404, 404'), d'une unité externe (250, 252, 258) et/ou d'un utilisateur (B') de l'unité externe (250, 252, 258) une libération pour la distribution imprévue de médicament.
  25. Utilisation d'au moins un dispositif (100; 100a; 100b) selon au moins l'une des revendications 1 à 14 et/ou du procédé selon au moins l'une des revendications 15 à 24 pour distribuer des médicaments, en particulier à un utilisateur (B) et/ou pour approvisionner en médicaments une ou plusieurs personnes, en particulier pour approvisionner en médicaments des personnes qui se trouvent sur plusieurs positions géographiques différentes.
EP19219741.6A 2019-01-25 2019-12-27 Dispositif de distribution des médicaments et procédé de fonctionnement associé Active EP3685815B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102019101891.9A DE102019101891A1 (de) 2019-01-25 2019-01-25 Vorrichtung zur Ausgabe von Medikamenten und Betriebsverfahren hierfür

Publications (3)

Publication Number Publication Date
EP3685815A1 EP3685815A1 (fr) 2020-07-29
EP3685815C0 EP3685815C0 (fr) 2023-06-07
EP3685815B1 true EP3685815B1 (fr) 2023-06-07

Family

ID=69055688

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19219741.6A Active EP3685815B1 (fr) 2019-01-25 2019-12-27 Dispositif de distribution des médicaments et procédé de fonctionnement associé

Country Status (2)

Country Link
EP (1) EP3685815B1 (fr)
DE (1) DE102019101891A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945651A (en) * 1997-07-17 1999-08-31 Chorosinski; Leonard Remotely programmable medication dispensing system
US20110121019A1 (en) * 2008-07-10 2011-05-26 2P2D Solutions Ltd. Device for Drug Distribution and Method of Using Thereof
CA2893013A1 (fr) * 2010-07-14 2012-01-14 Parata Systems, Llc Systeme pharmaceutique automatise pour la distribution de doses unitaires de produits pharmaceutiques et similaires
US9870670B2 (en) * 2012-03-20 2018-01-16 Tricopian, Llc Two-way exchange vending

Also Published As

Publication number Publication date
DE102019101891A1 (de) 2020-07-30
EP3685815C0 (fr) 2023-06-07
EP3685815A1 (fr) 2020-07-29

Similar Documents

Publication Publication Date Title
DE68917400T2 (de) Verfahren und Vorrichtung zum Transportieren einer behinderten Person.
DE10028839B4 (de) Verfahren und Vorrichtung zur Verlängerung der Nutzungsdauer eines schnurlosen Telefons während eines Stromausfalls
DE69916428T2 (de) Patientenbettüberwachung mit mikroprozessor
EP1876129B1 (fr) Méthode et dispositif pour réduire la consommation d'énergie d'un ascenseur.
DE69702449T2 (de) Vorrichtung zur transdermalen abgabe von medikamenten durch iontophorese
DE60028043T2 (de) Elektronisch gesteuerter spender für aufgerollte handtücher
DE1538493B2 (de) Verfahren und Schaltungsanordnunge zur direkten digitalen Regelung
DE102015218919B4 (de) Mobiles C-Bogen-Röntgengerät
DE212008000035U1 (de) Hochfrequenz (HF)-Wechselrichter
WO2017081113A1 (fr) Unité de surveillance pour une installation d'ascenseur et procédé associé
DE69926591T2 (de) Fehlersicherer Defribrillator
EP3685815B1 (fr) Dispositif de distribution des médicaments et procédé de fonctionnement associé
DE3604747C2 (fr)
DE69921468T2 (de) Abgabevorrichtung für Medikamente
EP2460109A2 (fr) Dispositif d'affichage pour un distributeur de doses de médicament et son utilisation
EP3494944A1 (fr) Lit de malade et son procédé de fonctionnement
CN109044849B (zh) 一种养老院老人服药辅助系统及其工作方法
CN115458098A (zh) 一种用于临床试验药物管理的控制系统
DE102018203763A1 (de) Vorrichtung und Verfahren zur unterbrechungsfreien Stromversorgung
EP3332304A1 (fr) Gestion de l'alimentation et protection contre une décharge totale
DE60113198T2 (de) System zur Detektion eines anormalen Zustands eines Anwenders im häuslichen Bereich
CN107978085A (zh) 一种可合并取药的药品管理系统
CN106446509A (zh) 基于指纹识别的智能出药方法及智能出药系统
EP3703021A1 (fr) Dispositif de distribution de médicaments et procédé de fonctionnement associé
DE202017007443U1 (de) Krankenbett

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210127

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/03 20060101ALN20221010BHEP

Ipc: A61J 7/04 20060101ALI20221010BHEP

Ipc: A61J 7/00 20060101AFI20221010BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20221122

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1572701

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230615

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502019007972

Country of ref document: DE

U01 Request for unitary effect filed

Effective date: 20230706

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20230718

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230907

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

U20 Renewal fee paid [unitary effect]

Year of fee payment: 5

Effective date: 20231213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502019007972

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20240308

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20231227